Jan 17 (Reuters) – Moderna Inc’s vaccine candidate against the Omicron coronavirus variant will enter clinical development in the next few weeks and the company expects to be able to share data with regulators around March, CEO Stephane Bancel said on Monday. “The vaccine is being finished … it should[Read More…]

Dec 28 (Reuters) – The Omicron variant was estimated to be 58.6% of the coronavirus variants circulating in the United States for the week ending Dec. 25, according to data from the U.S. Centers for Disease Control and Prevention (CDC). The fast-spreading variant was first detected in southern Africa and[Read More…]

Dec 22 (Reuters) – The World Health Organization does not yet have enough data on the new Omicron variant of the coronavirus to say if it is more severe than the Delta variant, an official said on Wednesday, almost a month after South Africa first raised the alarm about its[Read More…]

Dec 20 (Reuters) – A growing number of countries are reducing the wait time for COVID-19 vaccine boosters from six months to as few as three in a bid to ward off a new surge in infections from the Omicron variant. They are reacting to early evidence suggesting that Omicron[Read More…]

Dec 14 (Reuters) – Concerns over the Omicron coronavirus variant and fresh travel restrictions have led to a spike in hotel booking cancellations globally, online hotel search firm Trivago said on Tuesday, threatening to upend a fragile recovery in tourism. Cancellation rates increased to 35% since November and holiday travel[Read More…]

GENEVA, Dec 9 (Reuters) – The World Health Organization warned wealthy countries on Thursday against hoarding COVID-19 vaccines for booster shots as they try to fight off the new Omicron variant, threatening supplies to poorer countries where inoculation rates are low. Many Western nations have been rolling out boosters, targeting[Read More…]

WASHINGTON, Nov 22 (Reuters) – The White House is set to announce Monday that more than 90% of 3.5 million federal employees covered by a presidential COVID-19 vaccine mandate have received at least one vaccine dose ahead of a Monday deadline, Biden administration officials told Reuters. In total, the administration[Read More…]

WASHINGTON, Oct 29 (Reuters) – U.S. intelligence agencies said on Friday they may never be able to identify the origins of COVID-19, as they released a new, more detailed version of their review of whether the coronavirus came from animal-to-human transmission or leaked from a lab. The Office of the[Read More…]